Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Raw Materials: 2023-2024

  • Zhengye Biotechnology Holding's Raw Materials fell 25.65% to $1.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.0 million, marking a year-over-year decrease of 25.65%. This contributed to the annual value of $1.0 million for FY2024, which is 27.02% down from last year.
  • Per Zhengye Biotechnology Holding's latest filing, its Raw Materials stood at $1.0 million for Q4 2024, which was down 25.65% from $1.4 million recorded in Q4 2023.
  • Zhengye Biotechnology Holding's Raw Materials' 5-year high stood at $1.4 million during Q4 2023, with a 5-year trough of $1.0 million in Q4 2024.
  • In the last 2 years, Zhengye Biotechnology Holding's Raw Materials had a median value of $1.2 million in 2023 and averaged $1.2 million.
  • Data for Zhengye Biotechnology Holding's Raw Materials shows a maximum YoY dropped of 25.65% (in 2024) over the last 5 years.
  • Quarterly analysis of 2 years shows Zhengye Biotechnology Holding's Raw Materials stood at $1.4 million in 2023, then dropped by 25.65% to $1.0 million in 2024.